Aranda Pharma is a Finnish preclinical stage pharmaceutical company. We are developing novel non-steroidal small molecule inhibitors of the androgen receptor. Our molecules are advanced as locally acting anti-androgens for the topical treatment of acne and androgenetic alopecia. We utilise a cost-efficient business model with an international network of advisors, collaborators and service providers. We are looking for a partner for clinical development and commercialization of our ADA-308 antiandrogen asset. 

Contact us if you want to know more about potential partnerships or investments.